Bio-Quant's Drug Discovery provides unique collections of small molecules, peptides, and natural products against GPCRs targets. Using our compound collections, drug-like compounds can be evaluated against a client's target, using Bio-Quant's high-throughput screening platforms. Upon completion, leads are licensed exclusively to the Drug Discovery partners, accelerating the drug discovery process further toward the goal of a clinically important breakthrough.

Total Confidentiality
Secrecy is a powerful advantage in the competitive world of drug discovery. Bio-Quant understands and appreciates this concept and before discussion the collaboration and the target of interest, confidentiality agreements are executed between the Company and Bio-Quant.
Target Exclusivity
To maximize the value to clients and not enter into conflicts of interests, Bio-Quant screens on a target exclusive basis. This means that each and every assay can be an opportunity for a new discovery that may be unavailable to subsequent clients. The availability of the proposed target is evaluated confidentially at an early stage of discussions.
Detailed Research Plan
Before starting a partnership, Bio-Quant will develop a detailed research plan with the scientists of the potential partner. The plan will be developed once a business agreement is reached with the client. The comprehensive research plan will describe the assay, its development, and the goals of the Lead Compound Discovery project.
Assay Development
Like any new project, additional work might be needed to prepare the assay(s) for high-throughput screening. Assay development is defined broadly, from simple technology transfer to complete de novo development depending on the client's target and the assay's stage of development. Bio-Quant will apply the best technologies for measuring and screening of biomolecular interactions and functions of cells to reduce the expense and to improve the efficiency of the screening process. For example, the use of the 1536 microplates will reduce the cost and increase the speed of screening.

If you have reached this stage, this suggests that Bio-Quant Lead Compound Discovery can help your company to achieve its goals faster and more efficiently. If you are ready, please notify Dr. Bassam Damaj.
To receive more information:
Phone : 858.663-1159
Email : bdamaj@bio-quant.com